+
Site Tour

Search

Showing 1 - 10 of 532 results.

  • Connext

    Therapies Valvular Diseases Mitral Valve Disease Aortic Valve Disease Tricuspid Valvle Disease Paravalvular Leak

  • ESC GUIDELINES 2025 – ABBOTT AT ESC

    ESC Congress 2025 Shaping the Future of Structural Heart Therapies ESC Congress 2025 delivered powerful momentum in TEER and TAVI, with key updates that are now shaping clinical practice. Dive int

  • Overview

    Explore Now WATCH HOW TRICLIP™ TEER TRANSFORMED CRUZ'S LIFE FIND OUT MORE: DOWNLOAD FLYER LEARN MORE: PCR LV 2025 Symposium ESC/EACTS 2025 GUIDELINES Imaging Webinars 2025 E

  • Overview

    TREATMENT RANGE 4 MM TO 40 MM No other ASD closure device on the market today can match ASO’s wide range of device sizes.

  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion WATCH ON DEMAND: IMAGING WEBINARS 2025  LAAO SUMMIT 2025 LEARN MORE:

  • TMTI Landingpage

    TriClip™ TEER does not need long-term anticoagulation, minimizing complications associated with bleeding.14 ADVERSE EVENTS FROM PROCEDURE AND THROUGH 30 DAYS TRICLIP™ TEER SIGNIFICANT, SUSTAINED

  • Guidelines

    Summary of the current guidelines LEARN MORE: ESC/EACTS GUIDELINES 2025 The approach to mitral stenosis (MS) is evolving. Rheumatic MS is still treated with percutaneous mitral commissurotomy w

  • Imaging Webinars 2025

    ON DEMAND Imaging Webinars 2025 Echo guidance for screening and interventions in structural heart diseases PART 1: ANATOMICAL OVERVIEW IMAGING COURSES PART 2: MITRAL-TEER IMAGING COURSES PART 3

  • TAVI Webinar 2025

    ABBOTT TAVI WEBINARS 2025 When you aim at enhancing your skills by joining the advanced TAVI webinars together with P. MacCarthy, L. Conradi and a strong pool of experts, this webinar series is des

  • Overview

    TRI-SCORE RISK SCORE MODEL FOR ISOLATED TRICUSPID VALVE SURGERY Secondary TR arising from RV remodelling can be classified in three progressive stages26 Initial Right Ventricular (RV) dilatation

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline